BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8092350)

  • 1. Paroxetine and obsessive-compulsive disorder.
    Kaye NS; Dancu C
    Am J Psychiatry; 1994 Oct; 151(10):1523. PubMed ID: 8092350
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.
    Sasayama D; Sugiyama N; Imai J; Hayashida A; Harada Y; Amano N
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):251. PubMed ID: 19335398
    [No Abstract]   [Full Text] [Related]  

  • 3. Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology.
    Agid O; Lerer B
    J Clin Psychiatry; 1999 Jan; 60(1):55-6. PubMed ID: 10074882
    [No Abstract]   [Full Text] [Related]  

  • 4. Obsessive-compulsive disorder following cavernous sinus thrombosis.
    Garyfallos G; Papazisis G; Katsigiannopoulos K; Bozikas VP; Adamopoulou A
    J Neuropsychiatry Clin Neurosci; 2009; 21(4):473-4. PubMed ID: 19996263
    [No Abstract]   [Full Text] [Related]  

  • 5. Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.
    Heiden A; de Zwaan M; Frey R; Presslich O; Kasper S
    J Psychiatry Neurosci; 1998 May; 23(3):179-80. PubMed ID: 9595892
    [No Abstract]   [Full Text] [Related]  

  • 6. Secondary obsessive-compulsive disorder related to diaschisis after pontine infarction, successfully treated with paroxetine.
    Matsui T; Saxena S; Kawabe J; Matsunaga H; Kohagura K; Higashiyama S; Kiriike N
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):186-9. PubMed ID: 17362437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse of tic symptoms in a patient diagnosed with obsessive-compulsive disorder and treated with high-dose paroxetine.
    Lee MS; Lee HY; Kim SH
    J Child Adolesc Psychopharmacol; 2008 Jun; 18(3):305-6. PubMed ID: 18582189
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed-onset obsessive-compulsive symptoms after brain infarctions treated with paroxetine.
    Muneoka K; Shirayama Y; Kon K; Kawabe M; Kimura S
    Clin Neuropharmacol; 2011; 34(6):260-1. PubMed ID: 22104637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder.
    McDougle CJ; Barr LC; Goodman WK; Pelton GH; Aronson SC; Anand A; Price LH
    Am J Psychiatry; 1995 Dec; 152(12):1812-4. PubMed ID: 8526253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adderall for obsessive-compulsive disorder.
    Albucher RC; Curtis GC
    Am J Psychiatry; 2001 May; 158(5):818-9. PubMed ID: 11329414
    [No Abstract]   [Full Text] [Related]  

  • 12. Late-onset obsessive-compulsive disorder: the role of stressful life events.
    Velayudhan L; Katz AW
    Int Psychogeriatr; 2006 Jun; 18(2):341-4. PubMed ID: 16420720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
    Pato MT; Pigott TA; Hill JL; Grover GN; Bernstein S; Murphy DL
    Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
    Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
    Sevincok L; Topuz A
    J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit.
    Fontenelle LF; Mendlowicz MV; Versiani M
    Psychol Med; 2004 Jan; 34(1):181; author reply 181-3. PubMed ID: 14971639
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of severe obsessive-compulsive disorder with fluvoxamine.
    Price LH; Goodman WK; Charney DS; Rasmussen SA; Heninger GR
    Am J Psychiatry; 1987 Aug; 144(8):1059-61. PubMed ID: 3111279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomipramine for obsessive-compulsive symptoms.
    Szarek BL; Goethe JW
    Am J Psychiatry; 1988 Jul; 145(7):898-9. PubMed ID: 3289407
    [No Abstract]   [Full Text] [Related]  

  • 19. Obsessive-compulsive disorder and trazodone.
    Prasad AJ
    Am J Psychiatry; 1984 Apr; 141(4):612-3. PubMed ID: 6703152
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluvoxamine treatment of obsessive-compulsive disorder.
    Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R
    Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.